XML 19 R29.htm IDEA: XBRL DOCUMENT
v3.20.1

Entity Wide Disclosures (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2020
Entity Wide Disclosures [Abstract] |
Summary of Revenue by Major Source | The following table disaggregates our revenue by major source (in thousands):
|  | Three Months Ended March 31, 2020 |  |  | Three Months Ended March 31, 2019 |
Therapeutic Area |  |  |  |  |  |  |  |
Oncology |  | $ | 69,212 |  |  | $ | 55,962 |
Other |  |  | 50,569 |  |  |  | 46,869 |
Metabolic |  |  | 36,075 |  |  |  | 35,001 |
Cardiology |  |  | 25,899 |  |  |  | 22,650 |
AVAI |  |  | 25,147 |  |  |  | 19,924 |
Central Nervous System |  |  | 23,977 |  |  |  | 20,335 |
Total revenue |  | $ | 230,879 |  |  | $ | 200,741 |

X
- Definition Entity wide disclosures. + References No definition available. + Details
Name: | medp_EntityWideDisclosuresAbstract
Namespace Prefix: | medp_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Publisher FASB -Name Accounting Standards Codification -Topic 606 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=118956577&loc=SL49130545-203045 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration